China National Accord Medicines' low P/E ratio is due to its...
China National Accord Medicines' low P/E ratio is due to its projected growth being less than the broader market. Investors feel the potential for earnings growth doesn't warrant a higher P/E ratio, possibly limiting future share price increases.
Investors Aren't Buying China National Accord Medicines Corporation Ltd.'s (SZSE:000028) Earnings
Disclaimer: The above information does not represent the views of Moomoo Technologies Inc. (MTI) or constitute investment advice related to MTI and its affiliates.
Read more
Comment
Sign in to post a comment